Cargando…

Adenoviral gene transfer of tissue inhibitors of metalloproteinases (TIMPs) reduces the invasive behaviour of rheumatoid fibroblast-like synovicytes

Detalles Bibliográficos
Autores principales:	Van der Laan, WH, Huisman, L, Pieterman, E, Quax, PHA, TeKoppele, JM, Breedveld, FC, Verheijen, JH, Huizinga, TWJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273199/ http://dx.doi.org/10.1186/ar256

Ejemplares similares

Transfer of protease inhibitors to inhibit cartilage destruction
por: van der Laan, WH, et al.
Publicado: (2001)

Effects of TIMP-1 and TIMP-3 gene transfer on invasiveness, proliferation and apoptosis of rheumatoid arthritis (RA) synovial fibroblasts (RA-SF)
por: Pap, T, et al.
Publicado: (2002)

Invasion of synoviocytes is inhibited by gene transfer of TNF-BP or IL10 in an in vitro invasion model
por: Pieterman, E, et al.
Publicado: (2001)

MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
por: Tolboom, TCA, et al.
Publicado: (2001)

Factors influencing adenoviral gene transfer
por: Huizinga, TWJ, et al.
Publicado: (2001)

Fibroblast-like synoviocytes from rheumatoid arthritis patients express less flice-inhibitory protein than FLS from osteoarthritis, trauma and prosthesis loosening patie
por: Tolboom, TCA, et al.
Publicado: (2002)

A single nucleotide polymorphism on the IL-10 locus defines an expression polymorphism and a possible risk factor to develop RA
por: Lard, LR, et al.
Publicado: (2001)

Association between TNF -308A and systemic lupus erythematosus in relation to HLA-DR3 and six microsatellite markers on the short arm of chromosome VI
por: van der Linden, MW, et al.
Publicado: (2001)

Advanced glycation endproducts in the development of osteoarthritis
por: DeGroot, J, et al.
Publicado: (2004)

The invasiveness of fibroblast-like synoviocytes is of relevance for the rate of joint destruction in patients with rheumatoid arthritis and is a patient characteristic
por: Tolboom, TCA, et al.
Publicado: (2005)

A polymorphism in the IL-10 promoter affects autoantibody production and subsequent joint destruction in rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis
por: Hajizadeh, Shahin, et al.
Publicado: (2003)

Early treatment of recent-onset rheumatoid arthritis patients impairs the effect of HLA class II antigents on the progression of joint destruction
por: Lard, LR, et al.
Publicado: (2001)

Discovery of distinctive gene expression profiles in human arthritides by cDNA micro-array analysis
por: van der Pouw Kraan, TCTM, et al.
Publicado: (2002)

Autoantibodies predict progression to rheumatoid arthritis in undifferentiated arthritis: a prospective cohort study
por: van Gaalen, FA, et al.
Publicado: (2003)

Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
por: Joo, Y. E., et al.
Publicado: (1999)

Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Hepatocellular Carcinoma
por: Joo, Young-Eun, et al.
Publicado: (2000)

Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
por: Becher, Naja, et al.
Publicado: (2008)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion
por: Di Gregoli, Karina, et al.
Publicado: (2016)

Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs
por: Mandara, M.T., et al.
Publicado: (2017)

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
por: Glazewska, Edyta K., et al.
Publicado: (2018)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints of TNF-alpha transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

Fine-specificity of the antibodies against citrullinated protein response is influenced by shared epitope alleles
por: Verpoort, KN, et al.
Publicado: (2007)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
por: Okazaki, Isao, et al.
Publicado: (2014)

Elevated levels of tissue inhibitor of metalloproteinases (TIMPS) in human hepatocellular carcinomas
por: Matsumoto, Eiji, et al.
Publicado: (2004)

An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients
por: Demir, Nazlim Aktug, et al.
Publicado: (2023)

Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor
por: Tency, Inge, et al.
Publicado: (2012)

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma
por: Grzelczyk, Weronika Lucas, et al.
Publicado: (2019)

Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis
por: Bokarewa, Maria, et al.
Publicado: (2005)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes
por: Batra, Jyotica, et al.
Publicado: (2013)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia
por: Forsblom, Erik, et al.
Publicado: (2021)

Upregulation of matrix metalloproteinase 9 (MMP9)/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2/TIMP2 ratios may be involved in lipopolysaccharide-induced acute lung injury
por: Chen, Guobing, et al.
Publicado: (2020)

The Activity of Matrix Metalloproteinases (MMP-2, MMP-9) and Their Tissue Inhibitors (TIMP-1, TIMP-3) in the Cerebral Cortex and Hippocampus in Experimental Acanthamoebiasis
por: Łanocha-Arendarczyk, Natalia, et al.
Publicado: (2018)

Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and Their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain
por: Łukomska, Agnieszka, et al.
Publicado: (2020)

Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Regulates Hematopoiesis and Bone Formation In Vivo
por: Shen, Yi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_17efd477oir1mr0t4uc0gf0ppi